Oxford University Just Dropped £90 Million Developing A Coronavirus Vaccine. There’s Only One Problem.

(Tea Party 247) – An Oxford University coronavirus vaccine that has been rushed to human trials is now facing doubt after scientists express concern that all the monkeys used in testing…got coronavirus.


The British government has spent roughly £90 million on research so far, however, Dr. William Hasteline, a former Harvard Medical School professor, has revealed that the rhesus macaques monkeys who were administered the vaccine were found to have the same amount of virus in their noses as the non-vaccinated monkeys in the trial did.

“All of the vaccinated monkeys treated with the Oxford vaccine became infected when challenged.” Dr. Haseltine wrote, noting that “There was no difference in the amount of viral RNA detected from (nasal secretions) in the vaccinated monkeys as compared to the unvaccinated animals.”

“Which is to say, all vaccinated animals were infected,” he added.

“It is crystal clear that the vaccine did not provide sterilising immunity to the virus challenge, the gold standard for any vaccinem,” he also noted.

John Ball, a professor of molecular biology at Nottingham University said that the ChAdOx1 nCov-19 vaccine findings were “concerning”.

“The amount of virus genome detected in the noses of the vaccinated and un-vaccinated monkeys was the same and this is concerning.” Ball wrote.

“If this represents infectious virus and a similar thing occurs in humans, then vaccinated people can still be infected and shed large amounts of virus.” he added, warning that “This could potentially spread to others in the community.”

Eleanor Riley, a professor of immunobiology and infectious disease at Edinburgh University said the number of antibodies produced was by the subjects was “insufficient” to prevent infection and shedding of the virus.

“If similar results were obtained in humans, the vaccine would likely provide partial protection against disease in the recipient but would be unlikely to reduce transmission in the wider community,” Riley said.

Although much funding has been poured into the development of a vaccine, Newswars notes, researchers in California have discovered antibodies that can completely block COVID-19.

San Diego based Sorrento Therapeutics announced that an antibody named STI-1499 stopped coronavirus from entering 100 percent of healthy human cells in petri dish experiments.

The company has filed for emergency approval from the US Food and Drug Administration (FDA), promising that it can produce up to 200,000 doses of the antibody a month.

In further research at the University of Washington School of Medicine in Seattle, another antibody, called S309, was found to effectively target the ‘spike proteins’ found on the outside of the coronavirus, that are key to the invasion of human cells.

In a press release, researchers said that lab tests showed S309 attaches itself to the proteins, neutralizing them.

It will be interesting to observe whether the ineffective vaccine or the effective antibody research gets more funding going forward.


Please enter your comment!
Please enter your name here